PCSK9 and Hypercholesterolemia: The effects of GOF PCSK9 (Lu et al., 2016), which results in sustained hypercholesterolemia and increased atherosclerotic lesions in mice in vivo, are consistently more pronounced than the effects of WT PCSK9 in our study.